Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism
Author(s) -
Guy Meyer,
Éric Vicaut,
Thierry Danays,
Giancarlo Agnelli,
Cecilia Becattini,
Jan BeyerWestendorf,
Erich Bluhmki,
Hélène Bouvaist,
Benjamin Brenner,
Françis Couturaud,
Claudia Dellas,
Klaus Empen,
Ana Paula Figueiredo de Montalvão França,
Nazzareno Galiè,
Annette Geibel,
Samuel Z. Goldhaber,
David Jiménez,
Matija Kozak,
Christian Kupatt,
Nils Kucher,
Iréne Lang,
Mareike Lankeit,
Nicolas Méneveau,
G Pacouret,
Massimiliano Palazzini,
Antoniu Octavian Petriș,
Piotr Pruszczyk,
Matteo Rugolotto,
Aldo Salvi,
Sebastian Schellong,
Mustapha Sebbane,
Bożena Sobkowicz,
Branislav Stefanović,
Hölger Thiele,
Adam Torbicki,
Franck Verschuren,
Stavros Konstantinides
Publication year - 2014
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1302097
Subject(s) - fibrinolysis , pulmonary embolism , medicine , cardiology , venous thromboembolism , thrombosis
The role of fibrinolytic therapy in patients with intermediate-risk pulmonary embolism is controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom